A detailed history of Westover Capital Advisors, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Westover Capital Advisors, LLC holds 15,071 shares of BSX stock, worth $1.36 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
15,071
Previous 15,896 5.19%
Holding current value
$1.36 Million
Previous $1.22 Million 3.1%
% of portfolio
0.25%
Previous 0.32%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$72.96 - $84.0 $60,191 - $69,300
-825 Reduced 5.19%
15,071 $1.26 Million
Q2 2024

Aug 08, 2024

SELL
$67.33 - $77.71 $77,833 - $89,832
-1,156 Reduced 6.78%
15,896 $1.22 Million
Q1 2024

May 03, 2024

BUY
$57.6 - $68.62 $93,312 - $111,164
1,620 Added 10.5%
17,052 $1.17 Million
Q4 2023

Feb 06, 2024

SELL
$48.64 - $57.81 $11,235 - $13,354
-231 Reduced 1.47%
15,432 $892,000
Q3 2023

Nov 13, 2023

SELL
$50.19 - $54.68 $23,840 - $25,973
-475 Reduced 2.94%
15,663 $827,000
Q2 2023

Aug 11, 2023

SELL
$49.72 - $54.64 $55,686 - $61,196
-1,120 Reduced 6.49%
16,138 $872,000
Q1 2023

May 22, 2023

SELL
$45.09 - $50.03 $58,617 - $65,039
-1,300 Reduced 7.01%
17,258 $863,000
Q4 2022

May 18, 2023

SELL
$39.56 - $47.22 $3,956 - $4,722
-100 Reduced 0.54%
18,558 $858,000
Q3 2022

Nov 14, 2022

BUY
$36.71 - $109.66 $24,448 - $73,033
666 Added 3.7%
18,658 $723,000
Q2 2022

Aug 12, 2022

SELL
$35.24 - $47.1 $352 - $471
-10 Reduced 0.06%
17,992 $671,000
Q1 2022

May 13, 2022

BUY
$40.9 - $45.1 $446,832 - $492,717
10,925 Added 154.37%
18,002 $797,000
Q4 2021

Feb 14, 2022

BUY
$38.07 - $44.87 $52,155 - $61,471
1,370 Added 24.01%
7,077 $301,000
Q3 2021

Nov 15, 2021

BUY
$41.23 - $45.88 $33,767 - $37,575
819 Added 16.76%
5,707 $248,000
Q2 2021

Aug 10, 2021

BUY
$38.58 - $44.24 $188,579 - $216,245
4,888 New
4,888 $209,000
Q2 2020

Aug 14, 2020

SELL
$30.19 - $39.11 $271,347 - $351,520
-8,988 Closed
0 $0
Q1 2020

May 18, 2020

SELL
$25.83 - $45.71 $20,689 - $36,613
-801 Reduced 8.18%
8,988 $293,000
Q4 2019

Feb 11, 2020

SELL
$37.87 - $45.37 $12,875 - $15,425
-340 Reduced 3.36%
9,789 $443,000
Q3 2019

Nov 12, 2019

SELL
$40.31 - $43.45 $8,868 - $9,559
-220 Reduced 2.13%
10,129 $412,000
Q2 2019

Aug 13, 2019

SELL
$34.91 - $42.98 $12,323 - $15,171
-353 Reduced 3.3%
10,349 $445,000
Q1 2019

May 15, 2019

SELL
$32.91 - $40.75 $1,645 - $2,037
-50 Reduced 0.47%
10,702 $411,000
Q4 2018

Feb 14, 2019

BUY
$31.73 - $39.04 $341,160 - $419,758
10,752 New
10,752 $380,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Westover Capital Advisors, LLC Portfolio

Follow Westover Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westover Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Westover Capital Advisors, LLC with notifications on news.